Prognosis of Castration-resistant Prostate Cancer Patients - Use of the AdnaTest® System for Detection of Circulating Tumor Cells. [electronic resource]
- Anticancer research Apr 2016
- 2019-26 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1791-7530
Aged Aged, 80 and over Antineoplastic Agents--therapeutic use Docetaxel Humans Kaplan-Meier Estimate Male Middle Aged Neoplastic Cells, Circulating Prognosis Prostate-Specific Antigen--blood Prostatic Neoplasms, Castration-Resistant--blood Reverse Transcriptase Polymerase Chain Reaction Taxoids--therapeutic use Treatment Outcome